Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Objawy dolnych dróg moczowych
Total 0 results
Nothing found
Sponsors and Collaborators
West of Scotland Lymphoma Group
Pak Emirates Military Hospital Rawalpindi
Barth Wilsey
Institute of Population Research, Peking University
YuceBio Technology Co., Ltd.
Allorion Therapeutics Inc
S&T Medical Technologies, Inc.
Chin-Tsung Shen
CARERS TRUST (Carers Trust), UK
Zogenix, Inc.
Common Room Consulting Ltd
King Saud University
Michael Zell, MD
Mrs Hiroko Yuzawa, MD, PhD(c); Department of Intensive Care Medicine, Tokyo, Japan
Home care nursing in the Municipality of Esbjerg
Louisville VA Medical Center
OLVG
Department of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Romania
Cook County Health & Hospitals System
Momotaro-Gene Inc.
View Full List
Medical Conditions
Malalignment, Bone
Degenerative Lumbar Diseases
Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound
Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection)
Infant Amino Acid Profile at Day 3 and Discharge
Peripheral Microvascular Symptoms
Focus of the Study is Satiety
HR+HER2- Breast Cancer
Polyneuropathy and Mononeuropathies
Caridovascular Disease
Excitotoxicity
Sexual Wellbeing
Complications, Postoperative
HODGKIN LYMPHOMA
Antiphospholipid Syndrome
Platelet-aggregation Inhibitors
COPD - Chronic Obstructive Pulmonary Disease
Granulocyte/ Polymorphonuclear Cells
Locally Advanced or Metastatic Prostate Cancer.
View Full List
Drug Interventions
IDX-1197
Pre-study antiretroviral regimen
Nilotinib 400 mg BID
Cohort 2 Probe Substrate
Gardasil
Erenumab Dose 2
Dexmedetomidine injection
Linagliptin
Intensive chemotherapy
Standard care Hyaluronic acid eye drops
Pulmozyme
PP4001
GSK1247303
HM30181AK 15mg
Pleyris
4-Demethyl-4-cholestryloxycarbonylpenclomedine
Local medical treatment of raised intraocular pressure
Plerixafor
Lamictal
120 mg Pseudoephedrine hydrochloride extended release tablets
View Full List
CROs by country
Contract Research Organizations in Bahamas
Contract Research Organizations in Bahrain
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Colombia
Contract Research Organizations in Djibouti
Contract Research Organizations in Dominican Republic
Contract Research Organizations in El Salvador
Contract Research Organizations in Ethiopia
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Nigeria
Contract Research Organizations in Panama
Contract Research Organizations in Uzbekistan
Contract Research Organizations in Venezuela
CRO list by country
CROs in Mongolia
SGS
All CROs in Mongolia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe